266 related articles for article (PubMed ID: 38318177)
21. Differential regulation of sense and antisense promoter activity at the Csf1R locus in B cells by the transcription factor PAX5.
Ingram RM; Valeaux S; Wilson N; Bouhlel MA; Clarke D; Krüger I; Kulu D; Suske G; Philipsen S; Tagoh H; Bonifer C
Exp Hematol; 2011 Jul; 39(7):730-40.e1-2. PubMed ID: 21549805
[TBL] [Abstract][Full Text] [Related]
22. B-cell transcription factor expression and immunoglobulin gene rearrangement frequency in acute myeloid leukemia with t(8;21)(q22;q22).
Johnson RC; Ma L; Cherry AM; Arber DA; George TI
Am J Clin Pathol; 2013 Sep; 140(3):355-62. PubMed ID: 23955454
[TBL] [Abstract][Full Text] [Related]
23. Dynamic EBF1 occupancy directs sequential epigenetic and transcriptional events in B-cell programming.
Li R; Cauchy P; Ramamoorthy S; Boller S; Chavez L; Grosschedl R
Genes Dev; 2018 Jan; 32(2):96-111. PubMed ID: 29440261
[TBL] [Abstract][Full Text] [Related]
24. Ebf1 heterozygosity results in increased DNA damage in pro-B cells and their synergistic transformation by Pax5 haploinsufficiency.
Prasad MA; Ungerbäck J; Åhsberg J; Somasundaram R; Strid T; Larsson M; Månsson R; De Paepe A; Lilljebjörn H; Fioretos T; Hagman J; Sigvardsson M
Blood; 2015 Jun; 125(26):4052-9. PubMed ID: 25838350
[TBL] [Abstract][Full Text] [Related]
25. Stepwise activation of enhancer and promoter regions of the B cell commitment gene Pax5 in early lymphopoiesis.
Decker T; Pasca di Magliano M; McManus S; Sun Q; Bonifer C; Tagoh H; Busslinger M
Immunity; 2009 Apr; 30(4):508-20. PubMed ID: 19345119
[TBL] [Abstract][Full Text] [Related]
26. Immunologic regulation of bone development.
Horowitz MC; Lorenzo JA
Adv Exp Med Biol; 2007; 602():47-56. PubMed ID: 17966387
[TBL] [Abstract][Full Text] [Related]
27. Transcription factor EBF1 is essential for the maintenance of B cell identity and prevention of alternative fates in committed cells.
Nechanitzky R; Akbas D; Scherer S; Györy I; Hoyler T; Ramamoorthy S; Diefenbach A; Grosschedl R
Nat Immunol; 2013 Aug; 14(8):867-75. PubMed ID: 23812095
[TBL] [Abstract][Full Text] [Related]
28. Early B cell factor 1 regulates B cell gene networks by activation, repression, and transcription- independent poising of chromatin.
Treiber T; Mandel EM; Pott S; Györy I; Firner S; Liu ET; Grosschedl R
Immunity; 2010 May; 32(5):714-25. PubMed ID: 20451411
[TBL] [Abstract][Full Text] [Related]
29. B cell activator PAX5 promotes lymphomagenesis through stimulation of B cell receptor signaling.
Cozma D; Yu D; Hodawadekar S; Azvolinsky A; Grande S; Tobias JW; Metzgar MH; Paterson J; Erikson J; Marafioti T; Monroe JG; Atchison ML; Thomas-Tikhonenko A
J Clin Invest; 2007 Sep; 117(9):2602-10. PubMed ID: 17717600
[TBL] [Abstract][Full Text] [Related]
30. The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction.
Tagoh H; Ingram R; Wilson N; Salvagiotto G; Warren AJ; Clarke D; Busslinger M; Bonifer C
EMBO J; 2006 Mar; 25(5):1070-80. PubMed ID: 16482219
[TBL] [Abstract][Full Text] [Related]
31. Expression of the B cell-associated transcription factors PAX5, OCT-2, and BOB.1 in acute myeloid leukemia: associations with B-cell antigen expression and myelomonocytic maturation.
Gibson SE; Dong HY; Advani AS; Hsi ED
Am J Clin Pathol; 2006 Dec; 126(6):916-24. PubMed ID: 17074681
[TBL] [Abstract][Full Text] [Related]
32. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
[TBL] [Abstract][Full Text] [Related]
33. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.
Yu D; Allman D; Goldschmidt MH; Atchison ML; Monroe JG; Thomas-Tikhonenko A
Blood; 2003 Mar; 101(5):1950-5. PubMed ID: 12406913
[TBL] [Abstract][Full Text] [Related]
34. IL-7R signaling activates widespread V
Baizan-Edge A; Stubbs BA; Stubbington MJT; Bolland DJ; Tabbada K; Andrews S; Corcoran AE
Cell Rep; 2021 Jul; 36(2):109349. PubMed ID: 34260907
[TBL] [Abstract][Full Text] [Related]
35. MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies.
Ahmadi SE; Rahimi S; Zarandi B; Chegeni R; Safa M
J Hematol Oncol; 2021 Aug; 14(1):121. PubMed ID: 34372899
[TBL] [Abstract][Full Text] [Related]
36. Ebf1 in DNA repair and leukemogenesis.
Georgopoulos K
Blood; 2015 Jun; 125(26):3969-71. PubMed ID: 26113531
[TBL] [Abstract][Full Text] [Related]
37. Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia.
Heltemes-Harris LM; Hubbard GK; LaRue RS; Munro SA; Yang R; Henzler CM; Starr TK; Sarver AL; Kornblau SM; Farrar MA
Oncogene; 2021 Oct; 40(43):6166-6179. PubMed ID: 34535769
[TBL] [Abstract][Full Text] [Related]
38. Essential role of EBF1 in the generation and function of distinct mature B cell types.
Vilagos B; Hoffmann M; Souabni A; Sun Q; Werner B; Medvedovic J; Bilic I; Minnich M; Axelsson E; Jaritz M; Busslinger M
J Exp Med; 2012 Apr; 209(4):775-92. PubMed ID: 22473956
[TBL] [Abstract][Full Text] [Related]
39. Paired box gene 5 isoforms A and B have different functions in transcriptional regulation of B cell development-related genes in immature B cells.
Kikuchi H; Nakayama M; Kuribayashi F; Mimuro H; Imajoh-Ohmi S; Nishitoh H; Takami Y; Nakayama T
Microbiol Immunol; 2015 Jul; 59(7):426-31. PubMed ID: 26094714
[TBL] [Abstract][Full Text] [Related]
40. The regulation of the B-cell gene expression programme by Pax5.
Holmes ML; Pridans C; Nutt SL
Immunol Cell Biol; 2008 Jan; 86(1):47-53. PubMed ID: 17998914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]